{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:05:59Z","timestamp":1790355959143,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jamda.2016.05.015","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T01:31:02Z","timestamp":1466904662000},"page":"863.e1-863.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials"],"prefix":"10.1016","volume":"17","author":[{"given":"Kelvin K.F.","family":"Tsoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce Y.C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson W.Y.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoyee W.","family":"Hirai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Y.S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C.Y.","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2016.05.015_bib1","first-page":"759","article-title":"Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine","volume":"13","author":"Zemek","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jamda.2016.05.015_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: A randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2016.05.015_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2174\/156720508783884576","article-title":"Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial","volume":"5","author":"Porsteinsson","year":"2008","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.jamda.2016.05.015_bib4","unstructured":"National Institute for Clinical Excellence (NICE). Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease. Issued: March\u00a02011. London, England: National Institute for Clinical Excellence (NICE)."},{"key":"10.1016\/j.jamda.2016.05.015_bib5","series-title":"Memantine in Alzheimer's Disease. Executive Summary of Final Report A05e19C","year":"2009"},{"key":"10.1016\/j.jamda.2016.05.015_bib6","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.clinthera.2015.05.510","article-title":"Current practices in the treatment of Alzheimer disease: Where is the evidence after the phase III trials?","volume":"37","author":"Ehret","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/j.jamda.2016.05.015_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1159\/000343479","article-title":"Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias","volume":"2","author":"Muayqil","year":"2012","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.jamda.2016.05.015_bib8","doi-asserted-by":"crossref","first-page":"e000917","DOI":"10.1136\/bmjopen-2012-000917","article-title":"Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: A systematic review","volume":"2","author":"Farrimond","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/j.jamda.2016.05.015_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyu115","article-title":"Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: A systematic review and meta-analysis","volume":"18","author":"Matsunaga","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.jamda.2016.05.015_bib10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000359965","article-title":"Important error in \u2018Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer's Disease and Other Dementias\u2019 by Muayqil and Camicioli","volume":"4","author":"Tariot","year":"2014","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"10.1016\/j.jamda.2016.05.015_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jamda.2016.05.015_bib12","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2016.05.015_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.jamda.2016.05.015_bib14","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00002093-199700112-00005","article-title":"An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Galasko","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jamda.2016.05.015_bib15","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2016.05.015_bib16","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"The Alzheimer's Disease Cooperative Study: Validity and reliability of the Alzheimer's Disease Cooperative Study \u2013 Clinical Global Impression of Change","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jamda.2016.05.015_bib17","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2016.05.015_bib18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2016.05.015_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jamda.2016.05.015_bib20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000338236","article-title":"Efficacy and safety of donepezil 23 mg versus donepezil 10 mg for moderate-to-severe Alzheimer's disease: A subgroup analysis in patients already taking or not taking concomitant memantine","volume":"33","author":"Doody","year":"2012","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jamda.2016.05.015_bib21","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa1106668","article-title":"Donepezil and memantine for moderate- to-severe Alzheimer's disease","volume":"366","author":"Howard","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2016.05.015_bib22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/gps.4074","article-title":"The effects of combine treatment of memantine and donepezil on Alzheimer's disease patients and its relationship with cerebral blood flow in the prefrontal area","volume":"29","author":"Araki","year":"2014","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2016.05.015_bib23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/01.wad.0000213859.35355.59","article-title":"Activities of daily living in moderate-to-severe Alzheimer disease: An analysis of the treatment effects of memantine in patients receiving stable donepezil treatment","volume":"20","author":"Feldman","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jamda.2016.05.015_bib24","first-page":"2944","article-title":"Comparison of the efficacy of four cholinesterase inhibitors in combination with memantine for the treatment of Alzheimer's disease","volume":"8","author":"Shao","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jamda.2016.05.015_bib25","first-page":"415","article-title":"The efficacy and safety of combination therapy of memantine and donepezil among old Alzheimer's disease patients (Translated from Chinese)","volume":"4","author":"Zheng","year":"2011","journal-title":"Modern Practical Medicine"},{"key":"10.1016\/j.jamda.2016.05.015_bib26","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1185\/03007995.2011.582484","article-title":"Tolerability and efficacy of memantine add-on therapy to rivastigmine transdermal patches in mild to moderate Alzheimer's disease: A multicenter, randomized, open-label, parallel-group study","volume":"27","author":"Choi","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jamda.2016.05.015_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1185\/03007990903434914","article-title":"A\u00a025-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer's disease: A post hoc analysis","volume":"26","author":"Farlow","year":"2010","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jamda.2016.05.015_bib28","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.trci.2015.10.001","article-title":"Combined treatment with memantine and galantamine-CR compared with galantamine-CR only in antidementia drug na\u00efve patients with mild-to-moderate Alzheimer's disease","volume":"1","author":"Peters","year":"2015","journal-title":"Alzheimers Dement Transl Res Clin Interv"},{"key":"10.1016\/j.jamda.2016.05.015_bib29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2013.282834","article-title":"Effect of vitamin E and memantine on functional decline in Alzheimer disease: The TEAM-AD VA cooperative randomized trial","volume":"311","author":"Dysken","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2016.05.015_bib30","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s40263-013-0077-7","article-title":"The safety, tolerability, and efficacy of once-daily memantine (28 mg): A multinational, randomized, double- blind, placebo-controlled trial in patients with moderate-to- severe Alzheimer's disease taking cholinesterase inhibitors","volume":"27","author":"Grossberg","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jamda.2016.05.015_bib31","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1017\/S1041610213000239","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of memantine in a behaviorally enriched sample of patients with moderate-to-severe Alzheimer's disease","volume":"25","author":"Herrmann","year":"2013","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2016.05.015_bib32","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jamainternmed.2015.2152","article-title":"Cognitive tests to detect dementia. A systematic review and meta-analysis","volume":"175","author":"Tsoi","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2016.05.015_bib33","first-page":"391","article-title":"Effect of galantamine in a 2-year, randomized placebo-controlled study in Alzheimer's disease","volume":"10","author":"Hager","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.jamda.2016.05.015_bib34","doi-asserted-by":"crossref","first-page":"eS303","DOI":"10.1016\/j.eurpsy.2008.01.311","article-title":"Effect of memantine treatment at patients with moderate-severe Alzheimer's disease treated with Donepezil","volume":"23","author":"Szalontay","year":"2008","journal-title":"Eur Psychiatry"},{"key":"10.1016\/j.jamda.2016.05.015_bib35","doi-asserted-by":"crossref","first-page":"S550","DOI":"10.1016\/j.jalz.2010.05.1837","article-title":"Effect of combination therapy with memantine and rivastigmine patch on agitation behavior in patients with mild-to-moderate Alzheimer's disease: A 24-week prospective, multicenter, randomized, open-label clinical trial","volume":"6","author":"Yoon","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.jamda.2016.05.015_bib36","first-page":"641","article-title":"Effect of memantine treatment on patients with moderate-to-severe Alzheimer's disease treated with donepezil","volume":"112","author":"Cretu","year":"2008","journal-title":"Rev Med Chir Soc Med Nat Iasi"},{"key":"10.1016\/j.jamda.2016.05.015_bib37","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1177\/0269215510376004","article-title":"Cognitive stimulation therapy in the treatment of neuropsychiatric symptoms in Alzheimer's disease: A randomized controlled trial","volume":"24","author":"Niu","year":"2010","journal-title":"Clin Rehabil"},{"key":"10.1016\/j.jamda.2016.05.015_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1192\/bjp.183.3.248","article-title":"Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: Randomised controlled trial","volume":"183","author":"Spector","year":"2003","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jamda.2016.05.015_bib39","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/gps.1304","article-title":"A\u00a0pilot study examining the effectiveness of maintenance Cognitive Stimulation Therapy (MCST) for people with dementia","volume":"20","author":"Orrell","year":"2005","journal-title":"Int J Geriatr Psychiatry"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101630161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586101630161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:16:47Z","timestamp":1761506207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152586101630161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":39,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S152586101630161X"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2016.05.015","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination Therapy Showed Limited Superiority Over Monotherapy for Alzheimer Disease: A Meta-analysis of 14 Randomized Trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2016.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}